Novartis Investigative Site

Atakum / Samsun 55139

0 studies enrolling now · 2 studies all time

What they study most

Acute Decompensated Heart Failure, Congestive Heart Failure, Primary Progressive Multiple Sclerosis

Studies at this site

• This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS. — Stopped early
• Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure — Completed